OLALEKAN BADIRU: Open Payments
NPI 1114172467 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 71 payments from 9 companies in 2025. Trend: 2023 $1,638 · 2024 $1,417 · 2025 $1,923
Food & beverage: $1,923
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $441 |
| Otsuka America Pharmaceutical, Inc. | 13 | $340 |
| Neurocrine BioSciences, Inc. | 12 | $283 |
| Alkermes, Inc. | 10 | $269 |
| Lundbeck LLC | 9 | $254 |
| Janssen Pharmaceuticals, Inc | 10 | $251 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
Products named: ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, INGREZZA, VIVITROL, ABILIFY MAINTENA, ARISTADA, UZEDY.
Industry payments across NY — which companies pay providers there.
